| Application no. and date | 20204866.6 (espacenet) (Federated) (European Patent Register), 20140214 | | Patent/reg. no. and date | DK/EP 3889173, 20230705 | | Publication date | 20211006 | | Priority no. and date | US 201361765626 P, 20130215 | | EP pub. no. and date |
EP 3889173 20211006 | | Effective date | | | Applicant/owner | Bioverativ Therapeutics Inc., 225 Second Avenue
Waltham MA 02451, US | | Applicant ref. no. | 1686480 | | Inventor | TAN, Siyuan, 53 Buckman Drive
Lexington, MA 02421, US,
PETERS, Robert, T., 53 Parkinson Street
Needham, MA 02492, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | C07K 14/755 (2006.01) | | Title | OPTIMERET FAKTOR VIII-GEN | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Rettet DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
